| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 642.374.477 $ | 96,60 | 17.461.790 | |||||||
| UCB SA | UCB SA NPV | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 39.209.854 $ | 5,90 | 130.137 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 36.314.080 $ | 5,46 | 47.000 | |
| Pfizer Inc. | Pfizer Inc. COM | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 32.151.600 $ | 4,84 | 1.145.000 | |
| Gilead Sciences Inc. | Gilead Sciences Inc. COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 29.267.700 $ | 4,40 | 210.000 | |
| AbbVie Inc. | AbbVie Inc. COM | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 27.186.250 $ | 4,09 | 125.000 | |
| Merck & Co., Inc | Merck & Co., Inc COM | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 25.862.350 $ | 3,89 | 215.000 | |
| AstraZeneca PLC | AstraZeneca PLC ORD USD0.25 | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 25.663.256 $ | 3,86 | 131.243 | |
| Chugai Pharmaceutical Co Ltd. | Chugai Pharmaceutical Co Ltd. NPV | EC | JP3519400000 | Long | Modellwert (Stufe 2) | 24.816.818 $ | 3,73 | 450.000 | |
| Eli Lilly & Co. | Eli Lilly & Co. COM | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 23.914.020 $ | 3,60 | 26.000 | |
| Roche Holding AG | Roche Holding AG CHF0.001 | EP | CH1499059983 | Long | Modellwert (Stufe 2) | 21.949.996 $ | 3,30 | 55.000 | |
| UnitedHealth Group Inc. | UnitedHealth Group Inc. COM | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 18.941.300 $ | 2,85 | 70.000 | |
| Elevance Health Inc. | Elevance Health Inc. COM | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 18.443.250 $ | 2,77 | 63.000 | |
| Amgen Inc. | Amgen Inc. COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 16.536.950 $ | 2,49 | 47.000 | |
| Viatris Inc | Viatris Inc COM | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 15.806.943 $ | 2,38 | 1.170.018 | |
| Boston Scientific Corporation | Boston Scientific Corporation COM | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 15.687.500 $ | 2,36 | 250.000 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc COM | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 14.218.600 $ | 2,14 | 220.000 | |
| Sanofi SA | Sanofi SA EUR2 | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 11.588.379 $ | 1,74 | 120.000 | |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 11.163.500 $ | 1,68 | 25.000 | |
| Illumina Inc | Illumina Inc COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 11.093.400 $ | 1,67 | 90.000 | |
| Viking Therapeutics Inc. | Viking Therapeutics Inc. COM | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 10.741.454 $ | 1,62 | 330.100 | |
| Alkermes PLC | Alkermes PLC COM USD0.01 | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 10.254.400 $ | 1,54 | 290.000 | |
| Alnylam Pharmaceuticals Inc. | Alnylam Pharmaceuticals Inc. COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 9.926.100 $ | 1,49 | 30.000 | |
| Federal National Mortgage Association | Federal National Mortgage Association COM | EC | 313586109 | Long | Börsenkurs (Stufe 1) | 9.438.000 $ | 1,42 | 1.300.000 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd SHS | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 9.367.614 $ | 1,41 | 338.181 | |
| Neurocrine Biosciences Inc | Neurocrine Biosciences Inc COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 9.221.800 $ | 1,39 | 70.000 | |
| COGENT BIOSCIENCES INC | Cogent Biosciences Inc. COM | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 8.852.700 $ | 1,33 | 230.000 | |
| ARCUS BIOSCIENCES INC | Arcus Biosciences Inc. COM | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 8.188.560 $ | 1,23 | 379.100 | |
| Incyte Corporation. | Incyte Corporation. COM | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 7.529.600 $ | 1,13 | 80.000 | |
| Zimmer Biomet Holdings Inc | Zimmer Biomet Holdings Inc COM | EC | 98956P102 | Long | Börsenkurs (Stufe 1) | 7.233.600 $ | 1,09 | 80.000 | |
| Tarsus Pharmaceuticals Inc | Tarsus Pharmaceuticals Inc COM | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 7.015.000 $ | 1,05 | 100.000 | |
| Federal Home Loan Mortgage Corp. | Federal Home Loan Mortgage Corp. COM | EC | 313400301 | Long | Börsenkurs (Stufe 1) | 6.720.000 $ | 1,01 | 1.050.000 | |
| Quest Diagnostics Incorporated | Quest Diagnostics Incorporated COM | EC | 74834L100 | Long | Börsenkurs (Stufe 1) | 5.879.400 $ | 0,88 | 30.000 | |
| Biomarin Pharmaceutical Inc. | Biomarin Pharmaceutical Inc. COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 5.649.000 $ | 0,85 | 100.000 | |
| CVS Health Corp | CVS Health Corp COM | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 5.386.500 $ | 0,81 | 75.000 | |
| AnaptysBio Inc. | AnaptysBio Inc. COM | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 5.198.377 $ | 0,78 | 93.732 | |
| Biogen Inc | Biogen Inc COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 5.133.240 $ | 0,77 | 28.000 | |
| Abivax SA | Abivax SA SPONSORED ADS | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 5.010.750 $ | 0,75 | 45.000 | |
| Stryker Corporation | Stryker Corporation COM | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 4.928.850 $ | 0,74 | 15.000 | |
| Johnson & Johnson | Johnson & Johnson COM | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 4.888.800 $ | 0,74 | 20.000 | |
| VIR Biotechnology Inc | VIR Biotechnology Inc COM | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 4.480.000 $ | 0,67 | 500.000 | |
| GRAIL Inc | GRAIL Inc COM | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 4.392.800 $ | 0,66 | 85.000 | |
| Rigel Pharmaceuticals Inc. | Rigel Pharmaceuticals Inc. COM | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 4.326.400 $ | 0,65 | 160.000 | |
| Uniqure N.V. | Uniqure N.V. COM EUR0.05 | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 4.221.750 $ | 0,63 | 258.211 | |
| Syndax Pharmaceuticals Inc. | Syndax Pharmaceuticals Inc. COM | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 4.204.800 $ | 0,63 | 180.000 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc COM | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 3.664.290 $ | 0,55 | 7.000 | |
| Theravance Biopharma Inc | Theravance Biopharma Inc COM | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 3.388.548 $ | 0,51 | 208.783 | |
| Monte Rosa Therapeutics Inc | Monte Rosa Therapeutics Inc COM | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 3.290.000 $ | 0,49 | 200.000 | |
| Immunovant Inc | Immunovant Inc COM | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 3.032.964 $ | 0,46 | 122.100 | |
| Structure Therapeutics Inc | Structure Therapeutics Inc SPONSORED ADS | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 2.795.600 $ | 0,42 | 58.000 | |
| Perrigo Co PLC | Perrigo Co PLC | EC | IE00BGH1M568 | Long | Börsenkurs (Stufe 1) | 2.470.200 $ | 0,37 | 230.000 | |
| Xencor Inc | Xencor Inc COM | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 2.412.000 $ | 0,36 | 200.000 | |
| DAY ONE BIOPHARMACEUTICALS INC | Day One Biopharmaceuticals Inc. COM | EC | 23954D109 | Long | Börsenkurs (Stufe 1) | 2.358.400 $ | 0,35 | 110.000 | |
| COMPUGEN LTD | Compugen Ltd. ILS0.01 | EC | IL0010852080 | Long | Börsenkurs (Stufe 1) | 2.172.600 $ | 0,33 | 1.020.000 | |
| Acadia Pharmaceuticals Inc | Acadia Pharmaceuticals Inc COM | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 2.062.344 $ | 0,31 | 92.648 | |
| Arvinas Inc | Arvinas Inc COM | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 1.908.000 $ | 0,29 | 180.000 | |
| United Therapeutics Corporation | United Therapeutics Corporation COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 1.778.940 $ | 0,27 | 3.000 | |
| BioNTech SE | BioNTech SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 1.599.840 $ | 0,24 | 18.000 | |
| Coherus Oncology Inc. | Coherus Oncology Inc. COM | EC | 19249H103 | Long | Börsenkurs (Stufe 1) | 1.521.000 $ | 0,23 | 900.000 | |
| MoonLake Immunotherapeutics | MoonLake Immunotherapeutics CLASS A ORD | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 1.491.200 $ | 0,22 | 80.000 | |
| COSMO PHARMACEUTICALS NV | Cosmo Pharmaceuticals N.V. EUR0.26 (REGD) | EC | NL0011832936 | Long | Modellwert (Stufe 2) | 1.479.593 $ | 0,22 | 14.000 | |
| Ultragenyx Pharmaceuticals Inc | Ultragenyx Pharmaceuticals Inc COM | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 1.466.500 $ | 0,22 | 70.000 | |
| Regenxbio Inc. | Regenxbio Inc. COM | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 1.248.620 $ | 0,19 | 149.000 | |
| Nektar Therapeutics | Nektar Therapeutics COM NEW | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 1.229.769 $ | 0,18 | 17.092 | |
| Macrogenics Inc | Macrogenics Inc COM | EC | 556099109 | Long | Börsenkurs (Stufe 1) | 1.213.800 $ | 0,18 | 420.000 | |
| Vaxcyte Inc | Vaxcyte Inc COM | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 1.162.200 $ | 0,17 | 20.000 | |
| Janux Therapeutics Inc | Janux Therapeutics Inc COM | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 1.064.754 $ | 0,16 | 76.601 | |
| Moderna Inc | Moderna Inc COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 1.016.000 $ | 0,15 | 20.000 | |
| Proqr Therapeutics N.V | Proqr Therapeutics N.V COM EUR0.04 | EC | NL0010872495 | Long | Börsenkurs (Stufe 1) | 1.004.400 $ | 0,15 | 620.000 | |
| Cytokinetics Inc | Cytokinetics Inc COM NEW | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 988.650 $ | 0,15 | 15.000 | |
| OLEMA PHARMACEUTICALS INC | Olema Pharmaceuticals Inc. COM | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 745.500 $ | 0,11 | 50.000 | |
| Cellectis SA | Cellectis SA SPON ADS | EC | 15117K103 | Long | Börsenkurs (Stufe 1) | 719.194 $ | 0,11 | 226.875 | |
| Wave Life Sciences Ltd. | Wave Life Sciences Ltd. COM NPV | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 594.174 $ | 0,09 | 81.955 | |
| Viridian Therapeutics Inc | Viridian Therapeutics Inc COM | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 574.477 $ | 0,09 | 29.370 | |
| INSTIL BIO INC | Instil Bio Inc. COM NEW | EC | 45783C200 | Long | Börsenkurs (Stufe 1) | 412.000 $ | 0,06 | 50.000 | |
| Puma Biotechnology Inc | Puma Biotechnology Inc COM | EC | 74587V107 | Long | Börsenkurs (Stufe 1) | 391.419 $ | 0,06 | 61.255 | |
| Atea Pharmaceuticals Inc | Atea Pharmaceuticals Inc COM | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 376.600 $ | 0,06 | 70.000 | |
| Allogene Therapeutics Inc | Allogene Therapeutics Inc COM | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 358.141 $ | 0,05 | 146.779 | |
| Altimmune Inc. | Altimmune Inc. COM NEW | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 308.000 $ | 0,05 | 100.000 | |
| Intellia Therapeutics Inc | Intellia Therapeutics Inc COM | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 256.400 $ | 0,04 | 20.000 | |
| Sarepta Therapeutics Inc | Sarepta Therapeutics Inc COM | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 239.360 $ | 0,04 | 11.000 | |
| Myriad Genetics Inc. | Myriad Genetics Inc. COM | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 225.000 $ | 0,03 | 50.000 | |
| Rocket Pharmaceuticals Inc | Rocket Pharmaceuticals Inc COM | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 207.640 $ | 0,03 | 58.000 | |
| Karyopharm Therapeutics Inc | Karyopharm Therapeutics Inc COM NEW | EC | 48576U205 | Long | Börsenkurs (Stufe 1) | 185.665 $ | 0,03 | 33.333 | |
| Organon & Co | Organon & Co COMMON STOCK | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 176.705 $ | 0,03 | 29.500 | |
| Amarin Corp PLC | Amarin Corp PLC SPONSORED ADR | EC | 023111404 | Long | Börsenkurs (Stufe 1) | 137.370 $ | 0,02 | 9.500 | |
| Nextcure Inc | Nextcure Inc COM NEW | EC | 65343E207 | Long | Börsenkurs (Stufe 1) | 131.500 $ | 0,02 | 12.500 | |
| XOMA ROYALTY CORP | XOMA Royalty Corporation COM NEW | EC | 98419J206 | Long | Börsenkurs (Stufe 1) | 108.728 $ | 0,02 | 3.466 | |
| Sangamo Therapeutics Inc | Sangamo Therapeutics Inc COM | EC | 800677106 | Long | Börsenkurs (Stufe 1) | 98.760 $ | 0,01 | 400.000 | |
| Phio Pharmaceuticals Corp | Phio Pharmaceuticals Corp COM NEW | EC | 71880W501 | Long | Börsenkurs (Stufe 1) | 61.000 $ | 0,01 | 50.000 | |
| MIRATI THERAPEUTICS INC | MIRATI THERAPEUTICS INC | EC | Long | Schätzwert (Stufe 3) | 42.000 $ | 0,01 | 60.000 | ||
| LANDOS BIOPHARMA INC | LANDOS BIOPHARMA INC | EC | Long | Schätzwert (Stufe 3) | 36.942 $ | 0,01 | 14.718 | ||
| Lite Strategy Inc. | Lite Strategy Inc. COM | EC | 55279B301 | Long | Börsenkurs (Stufe 1) | 34.800 $ | 0,01 | 30.000 | |
| InnoCare Pharma Ltd | InnoCare Pharma Ltd USD0.000002 | EC | KYG4783B1032 | Long | Modellwert (Stufe 2) | 29.585 $ | 0,00 | 17.000 | |
| Contra Surface Oncolog | Contra Surface Oncolog | EC | Long | Modellwert (Stufe 2) | 26.950 $ | 0,00 | 350.000 | ||
| Voyager Therapeutics Incorporation | Voyager Therapeutics Incorporation COM | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 22.002 $ | 0,00 | 5.700 | |
| Fortress Biotech Inc | Fortress Biotech Inc COM NEW | EC | 34960Q307 | Long | Börsenkurs (Stufe 1) | 18.598 $ | 0,00 | 6.666 | |
| Akero Therapeutics Inc | Akero Therapeutics Inc | EC | 009CVR044 | Long | Schätzwert (Stufe 3) | 16.250 $ | 0,00 | 25.000 | |
| Euroapi SA | Euroapi SA EUR1 | EC | FR0014008VX5 | Long | Modellwert (Stufe 2) | 13.324 $ | 0,00 | 8.695 | |
| Galmed Pharmaceuticals Limited | Galmed Pharmaceuticals Limited COM ILS0.01 | EC | IL0011313900 | Long | Börsenkurs (Stufe 1) | 822 $ | 0,00 | 1.701 | |
| Mustang Bio Inc | Mustang Bio Inc COM | EC | 62818Q302 | Long | Börsenkurs (Stufe 1) | 116 $ | 0,00 | 160 | |
| SIO GENE THERAPIES INC | SIO GENE THERAPIES INC | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 64.171 | ||
| AMBIT BIOSCIENCES CORP CVR | AMBIT BIOSCIENCES CORP CVR | EC | Long | Schätzwert (Stufe 3) | beschränkt | 0 $ | 0,00 | 76.500 | |
| 642.374.477 $ | 96,60 | 17.461.790 |